id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-5817-0001,FDA,FDA-2026-N-5817,"Determination That Protamine Sulfate (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-06-08T04:00:00Z,2026,6,,,2026-06-08T16:51:28Z,2026-11429,0,0,09000064b931b84b